Cargando…

Serological markers associated with neuromyelitis optica spectrum disorders in South India

BACKGROUND: Neuromyelitis optica spectrum disorders (NMOSDs) represent 20% of all demyelinating disorders in South India. No studies have determined the seroprevalence to both antibodies against aquaporin-4* and antimyelin oligodendrocyte glycoprotein antibody (anti-MOG+) in this population. OBJECTI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pandit, Lekha, Sato, Douglas Kazutoshi, Mustafa, Sharik, Takahashi, Toshiyuki, D’Cunha, Anitha, Malli, Chaithra, Sudhir, Akshatha, Fujihara, Kazuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5144474/ https://www.ncbi.nlm.nih.gov/pubmed/27994362 http://dx.doi.org/10.4103/0972-2327.192389

Ejemplares similares

Relapsing optic neuritis and isolated transverse myelitis are the predominant clinical phenotypes for patients with antibodies to myelin oligodendrocyte glycoprotein in India
por: Pandit, Lekha, et al.
Publicado: (2016)

Clostridium bolteae is elevated in neuromyelitis optica spectrum disorder in India and shares sequence similarity with AQP4
por: Pandit, Lekha, et al.
Publicado: (2020)

Comparison of live and fixed cell-based assay performance: implications for the diagnosis of MOGAD in a low-middle income country
por: Pandit, Lekha, et al.
Publicado: (2023)

Evaluating the Role of HLA DRB1 Alleles and Oligoclonal Bands in Influencing Clinical Course of Multiple Sclerosis – A Study from the Mangalore Demyelinating Disease Registry
por: DCunha, Anitha, et al.
Publicado: (2021)

Environmental Factors Related to Multiple Sclerosis in Indian Population
por: Malli, Chaithra, et al.
Publicado: (2015)

Helicobacter pylori infection may influence prevalence and disease course in myelin oligodendrocyte glycoprotein antibody associated disorder (MOGAD) similar to MS but not AQP4-IgG associated NMOSD
por: Malli, Chaithra, et al.
Publicado: (2023)

Coexistence of Autoantibodies and Other Autoimmune Diseases with Multiple Sclerosis and Related Disorders – Experience from the Mangalore Demyelinating Disease Registry (MANDDIR)
por: Malli, Chaithra, et al.
Publicado: (2021)

Anti Myelin Oligodendrocyte Glycoprotein associated Immunoglobulin G (AntiMOG-IgG)-associated Neuromyelitis Optica Spectrum Disorder with Persistent Disease Activity and Residual Cognitive Impairment
por: Pandit, Lekha, et al.
Publicado: (2017)

Genetic variations in the Dravidian population of South West coast of India: Implications in designing case-control studies
por: D’Cunha, Anitha, et al.
Publicado: (2017)

Neuromyelitis optica spectrum disorders: An update
por: Pandit, Lekha
Publicado: (2015)

CD6 gene polymorphism rs17824933 is associated with multiple sclerosis in Indian population
por: D’Cunha, Mary Anitha, et al.
Publicado: (2016)

Optimizing the management of neuromyelitis optica and spectrum disorders in resource poor settings: Experience from the Mangalore demyelinating disease registry
por: Pandit, Lekha, et al.
Publicado: (2013)

Neuromyelitis optica spectrum disorders: still evolving and broadening
por: Fujihara, Kazuo
Publicado: (2019)

Th17 Cells Pathways in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders: Pathophysiological and Therapeutic Implications
por: Passos, Giordani Rodrigues Dos, et al.
Publicado: (2016)

Differential diagnosis of neuromyelitis optica spectrum disorders
por: Kim, Sung-Min, et al.
Publicado: (2017)

Progressive patterns of neurological disability in multiple sclerosis and neuromyelitis optica spectrum disorders
por: Akaishi, Tetsuya, et al.
Publicado: (2020)

Three cases of neuromyelitis optica spectrum disorder
por: Matsusue, Eiji, et al.
Publicado: (2016)

Transient Pulmonary Interstitial Lesions in Aquaporin-4-positive Neuromyelitis Optica Spectrum Disorder
por: Asato, Yuko, et al.
Publicado: (2018)

Interleukin-6 in neuromyelitis optica spectrum disorder pathophysiology
por: Fujihara, Kazuo, et al.
Publicado: (2020)

Cerebrospinal Fluid Aquaporin-4 Antibody Levels in Neuromyelitis Optica Attacks
por: Sato, Douglas Kazutoshi, et al.
Publicado: (2014)

Role of Glutamatergic Excitotoxicity in Neuromyelitis Optica Spectrum Disorders
por: da Silva, Ana Paula Bornes, et al.
Publicado: (2019)

Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
por: Ramanathan, Ramnath Santosh, et al.
Publicado: (2014)

MOG-IgG-Associated Optic Neuritis, Encephalitis, and Myelitis: Lessons Learned From Neuromyelitis Optica Spectrum Disorder
por: dos Passos, Giordani Rodrigues, et al.
Publicado: (2018)

Optic neuritis after ocular trauma in anti‐aquaporin‐4 antibody‐positive neuromyelitis optica spectrum disorder
por: Akaishi, Tetsuya, et al.
Publicado: (2021)

Disruption of the leptomeningeal blood barrier in neuromyelitis optica spectrum disorder
por: Asgari, Nasrin, et al.
Publicado: (2017)

Neuromyelitis optica spectrum disorders with unevenly clustered attack occurrence
por: Akaishi, Tetsuya, et al.
Publicado: (2019)

Neuromyelitis Optica Spectrum Disorder
por: Cazzaniga, Juliana, et al.
Publicado: (2023)

CH50 as a putative biomarker of eculizumab treatment in neuromyelitis optica spectrum disorder
por: Namatame, Chihiro, et al.
Publicado: (2021)

Severely exacerbated neuromyelitis optica rat model with extensive astrocytopathy by high affinity anti-aquaporin-4 monoclonal antibody
por: Kurosawa, Kazuhiro, et al.
Publicado: (2015)

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
por: Wingerchuk, Dean M., et al.
Publicado: (2015)

Update on biomarkers in neuromyelitis optica
por: Melamed, Esther, et al.
Publicado: (2015)

Early Treatment Initiation With Oral Prednisolone for Relapse Prevention Alleviates Depression and Fatigue in Aquaporin-4–Positive Neuromyelitis optica Spectrum Disorder
por: Akaishi, Tetsuya, et al.
Publicado: (2021)

Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide
por: Hor, Jyh Yung, et al.
Publicado: (2020)

Treatment of Neuromyelitis Optica Spectrum Disorders
por: Chan, Koon-Ho, et al.
Publicado: (2021)

Satralizumab for neuromyelitis optica spectrum disorder
Publicado: (2021)

Spectrum of sublytic astrocytopathy in neuromyelitis optica
por: Guo, Yong, et al.
Publicado: (2021)

Neuromyelitis optica spectrum disorders: a review with a focus on children and adolescents
por: Paolilo, Renata Barbosa, et al.
Publicado: (2023)

Circulating Memory T Follicular Helper Cells in Patients with Neuromyelitis Optica/Neuromyelitis Optica Spectrum Disorders
por: Fan, Xueli, et al.
Publicado: (2016)

Retinal Optical Coherence Tomography in Neuromyelitis Optica
por: Oertel, Frederike Cosima, et al.
Publicado: (2021)

Difference in the Source of Anti-AQP4-IgG and Anti-MOG-IgG Antibodies in CSF in Patients With Neuromyelitis Optica Spectrum Disorder
por: Akaishi, Tetsuya, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ubhc3gnnljdnq99kukit7m8knn